Tilray Brands Inc
TLRY
ISIN US88688T1007 / Valor 42386407
Tilray Brands Inc
UMushroom community rating:
About company
Tilray Brands Inc. is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids. The company prides itself on a scientific approach to product development, emphasizing active ingredients, standardized preparations, and consistent, measured dosing. Tilray's product portfolio is rigorously tested for potency and purity, ensuring high-quality offerings across various categories, including medicinal and recreational cannabis. Under the leadership of CEO Irwin D. Simon, who has over 30 years of experience in building consumer packaged goods companies, Tilray has positioned itself as a leader in the global cannabis market. Simon's previous success in transforming Aphria Inc. into a profitable entity and his foundational role at The Hain Celestial Group highlight his capability to steer Tilray towards significant growth and market share. The company's operational excellence spans from cultivation to shipping, with a focus on precision, professionalism, and care at every stage of the process, aiming to deliver unparalleled products to its patients and consumers.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Net Revenue Growth
Tilray Brands Inc. reported net revenue of $188.3 million for the third quarter of fiscal 2024, marking a significant increase of approximately 30% compared to $145.6 million in the same quarter of the previous year. This growth was driven by strong performance across various segments, including cannabis and beverage-alcohol.
Beverage-Alcohol Segment
The beverage-alcohol segment saw a remarkable net revenue increase of 165%, reaching $54.7 million in Q3 2024, up from $20.6 million in the prior year quarter. This surge was attributed to the acquisition of new craft brands, while existing brands maintained consistent performance.
Cannabis Segment Performance
Cannabis net revenue for Tilray Brands Inc. increased by 33% to $63.4 million in the third quarter of fiscal 2024, compared to $47.5 million in the same period last year. This growth was driven by acquisitions and increased sales in Canadian medical, adult-use, wholesale, and international markets.
Net Loss Reduction
Tilray Brands Inc. reported a net loss of $105.0 million for Q3 2024, a significant improvement from the net loss of $1.2 billion in the prior year quarter. The net loss per share also narrowed to ($0.12) from ($1.90) in the previous year quarter.
Adjusted EBITDA
Adjusted EBITDA for Tilray Brands Inc. was $10.2 million in the third quarter of fiscal 2024, compared to $13.3 million in the same quarter of the previous year. Despite the decrease, the company maintained a strong financial liquidity position with approximately $226 million in cash and marketable securities.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1370 M
Market cap (USD)
2,440,643
Daily traded volume (Shares)
1.355 / 1.285
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Robin Roten
Tej Ram Kumpakha
EQUITIES OF THE SAME SECTOR
